120 related articles for article (PubMed ID: 21897294)
21. Simvastatin reduces sympathetic outflow and augments endothelium-independent dilation in non-hyperlipidaemic primary hypertension.
McGowan CL; Murai H; Millar PJ; Notarius CF; Morris BL; Floras JS
Heart; 2013 Feb; 99(4):240-6. PubMed ID: 23257173
[TBL] [Abstract][Full Text] [Related]
22. Salt supresses baseline muscle sympathetic nerve activity in salt-sensitive and salt-resistant hypertensives.
Abrahão SB; Tinucci T; Santello JL; Mion D
J Hum Hypertens; 2002 Dec; 16(12):843-50. PubMed ID: 12522465
[TBL] [Abstract][Full Text] [Related]
23. Sympathetic hyperactivity in hypertensive chronic kidney disease patients is reduced during standard treatment.
Neumann J; Ligtenberg G; Klein IH; Boer P; Oey PL; Koomans HA; Blankestijn PJ
Hypertension; 2007 Mar; 49(3):506-10. PubMed ID: 17224471
[TBL] [Abstract][Full Text] [Related]
24. Dyslipidaemia as predictor of progressive renal failure and the impact of treatment with atorvastatin.
Ozsoy RC; van der Steeg WA; Kastelein JJ; Arisz L; Koopman MG
Nephrol Dial Transplant; 2007 Jun; 22(6):1578-86. PubMed ID: 17347284
[TBL] [Abstract][Full Text] [Related]
25. Effects of statins on renal sodium and water handling: acute and short-term effects of atorvastatin on renal haemodynamics, tubular function, vasoactive hormones, blood pressure and pulse rate in healthy, normocholesterolemic humans.
Paulsen L; Holm C; Bech JN; Starklint J; Pedersen EB
Nephrol Dial Transplant; 2008 May; 23(5):1556-61. PubMed ID: 18065809
[TBL] [Abstract][Full Text] [Related]
26. Sympathetic hyperactivity in haemodialysis patients is reduced by short daily haemodialysis.
Zilch O; Vos PF; Oey PL; Cramer MJ; Ligtenberg G; Koomans HA; Blankestijn PJ
J Hypertens; 2007 Jun; 25(6):1285-9. PubMed ID: 17563543
[TBL] [Abstract][Full Text] [Related]
27. Statins do not significantly affect muscle sympathetic nerve activity in humans with nonischemic heart failure: a double-blind placebo-controlled trial.
Horwich TB; Middlekauff HR; Maclellan WR; Fonarow GC
J Card Fail; 2011 Nov; 17(11):879-86. PubMed ID: 22041323
[TBL] [Abstract][Full Text] [Related]
28. Association between the changes in renal function and serum uric acid levels during multifactorial intervention and clinical outcome in patients with metabolic syndrome. A post hoc analysis of the ATTEMPT study.
Athyros VG; Karagiannis A; Ganotakis ES; Paletas K; Nicolaou V; Bacharoudis G; Tziomalos K; Alexandrides T; Liberopoulos EN; Mikhailidis DP;
Curr Med Res Opin; 2011 Aug; 27(8):1659-68. PubMed ID: 21714711
[TBL] [Abstract][Full Text] [Related]
29. Safety and efficacy of atorvastatin in patients with severe renal dysfunction.
Holmberg B; Brännström M; Bucht B; Crougneau V; Dimeny E; Ekspong A; Granroth B; Gröntoft KC; Hadimeri H; Ingman B; Isaksson B; Johansson G; Lindberger K; Lundberg L; Mikaelsson L; Olausson E; Persson B; Welin D; Wikdahl AM; Stegmayr BG
Scand J Urol Nephrol; 2005; 39(6):503-10. PubMed ID: 16303728
[TBL] [Abstract][Full Text] [Related]
30. Tonic chemoreflex activation contributes to the elevated muscle sympathetic nerve activity in patients with chronic renal failure.
Hering D; Zdrojewski Z; Król E; Kara T; Kucharska W; Somers VK; Rutkowski B; Narkiewicz K
J Hypertens; 2007 Jan; 25(1):157-61. PubMed ID: 17143187
[TBL] [Abstract][Full Text] [Related]
31. Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) study.
Shepherd J; Kastelein JJ; Bittner V; Deedwania P; Breazna A; Dobson S; Wilson DJ; Zuckerman A; Wenger NK;
Clin J Am Soc Nephrol; 2007 Nov; 2(6):1131-9. PubMed ID: 17942759
[TBL] [Abstract][Full Text] [Related]
32. Atorvastatin therapy increases heart rate variability, decreases QT variability, and shortens QTc interval duration in patients with advanced chronic heart failure.
Vrtovec B; Okrajsek R; Golicnik A; Ferjan M; Starc V; Radovancevic B
J Card Fail; 2005 Dec; 11(9):684-90. PubMed ID: 16360963
[TBL] [Abstract][Full Text] [Related]
33. Systemic evaluation of gene expression changes in major target organs induced by atorvastatin.
Kato N; Liang YQ; Ochiai Y; Jesmin S
Eur J Pharmacol; 2008 Apr; 584(2-3):376-89. PubMed ID: 18295756
[TBL] [Abstract][Full Text] [Related]
34. Impact of statin therapy on central aortic pressures and hemodynamics: principal results of the Conduit Artery Function Evaluation-Lipid-Lowering Arm (CAFE-LLA) Study.
Williams B; Lacy PS; Cruickshank JK; Collier D; Hughes AD; Stanton A; Thom S; Thurston H;
Circulation; 2009 Jan; 119(1):53-61. PubMed ID: 19103995
[TBL] [Abstract][Full Text] [Related]
35. Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis.
Onuigbo MA; Onuigbo NT
QJM; 2008 Jul; 101(7):519-27. PubMed ID: 18375475
[TBL] [Abstract][Full Text] [Related]
36. Statin therapy helps to control blood pressure levels in hypertensive dyslipidemic patients.
Kanbay M; Yildirir A; Bozbas H; Ulus T; Bilgi M; Muderrisoglu H; Akcay A; Ozdemir FN
Ren Fail; 2005; 27(3):297-303. PubMed ID: 15957546
[TBL] [Abstract][Full Text] [Related]
37. Differential effects of lipophilic and hydrophilic statins on muscle sympathetic nerve activity in heart failure with preserved left ventricular ejection fraction.
Tokuhisa H; Murai H; Okabe Y; Hamaoka T; Sugimoto H; Mukai Y; Inoue O; Takashima SI; Kato T; Usui S; Furusho H; Kaneko S; Takamura M
Auton Neurosci; 2018 Sep; 213():8-14. PubMed ID: 30005743
[TBL] [Abstract][Full Text] [Related]
38. Use of atorvastatin in hyperlipidemic hypertensive renal transplant recipients.
Krmar RT; Ferraris JR; Ramirez JA; Sorroche P; Legal S; Cayssials A
Pediatr Nephrol; 2002 Jul; 17(7):540-3. PubMed ID: 12172771
[TBL] [Abstract][Full Text] [Related]
39. Effects of atorvastatin on low-density lipoprotein cholesterol phenotype and C-reactive protein levels in patients undergoing long-term dialysis.
Dornbrook-Lavender KA; Joy MS; Denu-Ciocca CJ; Chin H; Hogan SL; Pieper JA
Pharmacotherapy; 2005 Mar; 25(3):335-44. PubMed ID: 15843280
[TBL] [Abstract][Full Text] [Related]
40. Atorvastatin reduces arterial stiffness in patients with rheumatoid arthritis.
Van Doornum S; McColl G; Wicks IP
Ann Rheum Dis; 2004 Dec; 63(12):1571-5. PubMed ID: 15547080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
